In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Ranbir Kapoor ready to marry Alia Bhatt said- I will take seven rounds soon, but...
The news of Ranbir Kapoor and Alia Bhatt's wedding has been in the news for quite some time. Rece
French President Emmanuel Macron met with Ukrainian President Volodymyr Zelensky late on 8 Februa
People are troubled by heat and heat waves in many parts of the country. However, for the last fe
The Supreme Court on Monday expressed strong displeasure over the filing of a new petition regard
Friendship Day 2023: Friendship is the valuable wealth of a person's life. It is such a relations
Diwali is the most important festival of Hinduism, which everyone eagerly awaits throughout the y
There has been a decrease in the foreign currency assets of the country again. It has registered
Pooja Khedkar, who has been embroiled in controversies for a long time, is facing troubles that a
In Iran, anti-hijab agitations continue after Mahsa Amini's health deteriorated and then died in
The second day of the Wimbledon Championships 2023 will be named after former tennis player Roger
